GlassScriptPhysician profile
Brittany A Bryan
NPI 1104189315
$1,964.32
in general payments reported to CMS, 2019-2025
10 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $570 · 2020: $234 · 2022: $538 · 2023: $72.14 · 2024: $332 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $673.09 | 2019-2025 | Evenity |
| Janssen Pharmaceuticals, INC | $289.87 | 2019-2023 | Xarelto |
| Abbvie INC. | $246.32 | 2022-2024 | |
| Novo Nordisk INC | $197.13 | 2022-2025 | Ozempic |
| Edwards Lifesciences Corporation | $178.50 | 2024 | Sapien 3 Ultra Resilia |
| Mylan Specialty L.P. | $117.38 | 2020 | |
| Tetraphase Pharmaceuticals, INC. | $108.42 | 2019 | |
| Lilly USA, LLC | $104.18 | 2025 | Zepbound |
| Grifols USA, LLC | $29.37 | 2024 | Prolastin-C Liquid |
| E.R. Squibb & Sons, L.L.C. | $20.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Bryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.